Trial intelligence / Profile preview

UA Vaginal Ring and LNG for Ovulation Inhibition

NCT02451826Phase 2Unknown

Sponsor
Population Council
Start
May 2015
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ulipristal in pregnancy, sponsored by Population Council. Primary endpoint: Pharmacodynamic efficacy on the endometrium at 3 months. Status: unknown.

02

Drugs

ulipristal
03

Conditions

pregnancy

Beyond the preview

Go deeper on NCT02451826.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02451826.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call